SLS

SELLAS Life Sciences Group (SLS)

About SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Details

Daily high

$3.00

Daily low

$2.73

Price at open

$2.78

52 Week High

$3.00

52 Week Low

$0.85

Market cap

404.5M

Dividend yield

0.00%

Volume

6.2M

Avg. volume

6.3M

P/E ratio

-9.90

SELLAS Life Sciences Group News

Details

Daily high

$3.00

Daily low

$2.73

Price at open

$2.78

52 Week High

$3.00

52 Week Low

$0.85

Market cap

404.5M

Dividend yield

0.00%

Volume

6.2M

Avg. volume

6.3M

P/E ratio

-9.90